— Know what they know.
Not Investment Advice
Also trades as: 0M3Q.L (LSE) · $vol 1M · ZOE.DE (XETRA) · $vol 0M

ZTS NYSE

Zoetis Inc.
1W: +6.0% 1M: -31.9% 3M: -37.8% YTD: -36.1% 1Y: -50.8% 3Y: -54.6% 5Y: -51.5%
$81.32
+1.25 (+1.56%)
 
Weekly Expected Move ±11.3%
$58 $66 $74 $83 $91
NYSE · Healthcare · Drug Manufacturers - General · Alpha Radar Sell · Power 42 · $34.1B mcap · 418M float · 1.29% daily turnover · Short 33% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
61.7 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 27.2%  ·  5Y Avg: 24.4%
Cost Advantage
75
Intangibles
42
Switching Cost
68
Network Effect
48
Scale ★
80
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ZTS has a Narrow competitive edge (61.7/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 27.2% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$95
Low
$104
Avg Target
$115
High
Based on 4 analysts since May 7, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 15Hold: 14Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$117.33
Analysts6
Consensus Change History
DateFieldFromTo
2026-05-19 consensus Hold Buy
2026-02-13 consensus Buy Hold
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-22 Stifel Nicolaus $105 $95 -10 +18.7% $80.06
2026-05-15 Morgan Stanley Erin Wright $160 $115 -45 +51.2% $76.06
2026-05-08 UBS $130 $99 -31 +18.9% $83.27
2026-05-08 Stifel Nicolaus $140 $105 -35 +20.3% $87.31
2026-04-28 UBS $136 $130 -6 +11.4% $116.71
2026-02-26 BTIG Mark Massaro Initiated $160 +24.1% $128.95
2026-01-29 UBS $158 $136 -22 +10.8% $122.75
2026-01-22 Piper Sandler David Westenberg $215 $135 -80 +7.9% $125.08
2025-12-18 Morgan Stanley $243 $160 -83 +28.5% $124.54
2025-12-10 HSBC Initiated $140 +21.0% $115.75
2025-12-08 Barclays $242 $136 -106 +15.1% $118.16
2025-11-04 Stifel Nicolaus $160 $140 -20 +11.6% $125.50
2025-10-20 UBS $170 $158 -12 +9.0% $144.90
2025-08-11 Piper Sandler David Westenberg $195 $215 +20 +44.4% $148.86
2025-06-17 Stifel Nicolaus Jonathan Block $165 $160 -5 -1.0% $161.67
2025-05-07 UBS Andrea Alfonso Initiated $170 +13.4% $149.87
2025-04-14 Stifel Nicolaus Jonathan Block $200 $165 -35 +9.4% $150.83
2025-02-04 Morgan Stanley Erin Wright $248 $243 -5 +41.1% $172.24
2024-08-07 Barclays Balaji Prasad Initiated $242 +30.6% $185.29
2024-08-05 Stifel Nicolaus Jonathan Block $195 $200 +5 +13.4% $176.31
2024-04-16 Piper Sandler David Westenberg Initiated $195 +30.2% $149.77
2024-04-02 Stifel Nicolaus Jonathan Block Initiated $195 +16.8% $167.02
2022-11-15 Morgan Stanley Initiated $248 +65.1% $150.25
2022-02-20 Jefferies David Steinberg Initiated $254 +32.8% $191.32
2021-08-24 Argus Research Jasper Hellweg Initiated $225 +10.4% $203.86
2021-08-08 Credit Suisse Katie Tryhane Initiated $230 +15.5% $199.16

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
May 22, 2026
DCF
5
ROE
5
ROA
5
D/E
1
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ZTS receives an overall rating of B+. Strongest factors: DCF (5/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-20 A- B+
2026-05-12 A A-
2026-05-08 B+ A
2026-01-16 A- B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

64 Grade A
Profitability
98
Balance Sheet
60
Earnings Quality
76
Growth
51
Value
54
Momentum
67
Safety
100
Cash Flow
57
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ZTS scores highest in Safety (100/100) and lowest in Growth (51/100). An overall grade of A places ZTS among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
5.44
Safe Zone
Piotroski F-Score
8/9
Beneish M-Score
-2.33
Unlikely Manipulator
Ohlson O-Score
-7.36
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
AA-
Score: 83.1/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.03x
Accruals: -0.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ZTS scores 5.44, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ZTS scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ZTS's score of -2.33 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ZTS's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ZTS receives an estimated rating of AA- (score: 83.1/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ZTS's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
12.99x
PEG
1.58x
P/S
3.59x
P/B
10.62x
P/FCF
23.38x
P/OCF
18.37x
EV/EBITDA
14.14x
EV/Revenue
6.01x
EV/EBIT
16.07x
EV/FCF
26.74x
Earnings Yield
5.29%
FCF Yield
4.28%
Shareholder Yield
8.59%
Graham Number
$33.32
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 13.0x earnings, ZTS trades at a reasonable valuation. An earnings yield of 5.3% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $33.32 per share, 144% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.799
NI / EBT
×
Interest Burden
0.931
EBT / EBIT
×
EBIT Margin
0.374
EBIT / Rev
×
Asset Turnover
0.640
Rev / Assets
×
Equity Multiplier
3.667
Assets / Equity
=
ROE
65.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ZTS's ROE of 65.3% is driven by financial leverage (equity multiplier: 3.67x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
11.97%
Fair P/E
32.43x
Intrinsic Value
$202.95
Price/Value
0.58x
Margin of Safety
41.75%
Premium
-41.75%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ZTS's realized 12.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $202.95, ZTS appears undervalued with a 42% margin of safety. The adjusted fair P/E of 32.4x compares to the current market P/E of 13.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$81.32
Median 1Y
$76.45
5th Pctile
$47.69
95th Pctile
$122.63
Ann. Volatility
29.8%
Analyst Target
$117.33
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Kristin C. Peck
Chief Executive Officer
$1,300,000 $9,562,347 $17,206,760
Wetteny Joseph (“EVP”)
ve Vice President (“EVP”) and Chief Financial Officer
$750,000 $2,390,440 $5,089,461
Heidi C. Chen
Former EVP, General Counsel and Corporate Secretary; Business Lead of Human Health Diagnostics
$346,808 $1,060,885 $3,621,101
Jamie Brannan EVP
and Chief Commercial Officer
$659,423 $910,910 $3,024,611
Robert J. Polzer
EVP and President of Research and Development
$660,000 $1,087,447 $2,973,038
Wafaa Mamilli EVP,
er EVP, Chief Digital and Technology Officer and Group President for China, Brazil and Precision Animal Health
$650,000 $1,034,593 $2,784,279
Roxanne Lagano EVP,
General Counsel and Corporate Secretary
$620,833 $937,202 $2,615,155

CEO Pay Ratio

105:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $17,206,760
Avg Employee Cost (SGA/emp): $164,000
Employees: 14,500

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
14,500
+5.1% YoY
Revenue / Employee
$652,897
Rev: $9,467,000,000
Profit / Employee
$184,345
NI: $2,673,000,000
SGA / Employee
$164,000
Avg labor cost proxy
R&D / Employee
$48,138
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 58.9% 61.2% 49.0% 49.9% 50.3% 49.7% 47.3% 46.3% 49.5% 51.0% 49.9% 50.9% 49.9% 51.7% 50.9% 51.6% 53.5% 54.3% 66.0% 65.3% 65.25%
ROA 15.2% 15.8% 14.8% 15.1% 15.2% 15.0% 14.7% 14.4% 15.4% 15.8% 16.0% 16.4% 16.0% 16.6% 17.4% 17.7% 18.3% 18.6% 18.0% 17.8% 17.80%
ROIC 28.7% 29.8% 29.4% 29.8% 29.6% 29.2% 26.1% 25.3% 26.1% 27.1% 25.2% 25.9% 26.8% 27.4% 28.4% 28.5% 29.2% 29.5% 27.2% 27.2% 27.16%
ROCE 22.6% 23.1% 22.5% 22.8% 23.1% 23.1% 24.6% 24.5% 26.2% 26.7% 25.7% 26.1% 25.3% 26.6% 31.2% 31.7% 32.8% 32.9% 27.2% 26.9% 26.85%
Gross Margin 68.7% 68.5% 67.5% 69.3% 67.7% 67.8% 66.3% 68.8% 70.5% 68.6% 65.4% 68.9% 70.2% 69.2% 68.0% 70.5% 72.3% 70.2% 68.9% 71.7% 71.66%
Operating Margin 37.2% 36.6% 30.3% 39.7% 35.4% 36.1% 33.8% 36.4% 38.3% 37.1% 32.0% 36.6% 38.4% 38.5% 33.0% 38.1% 40.2% 39.0% 34.6% 36.3% 36.34%
Net Margin 26.3% 27.7% 21.0% 30.0% 25.8% 26.4% 22.6% 27.6% 30.8% 27.7% 23.7% 27.4% 26.4% 28.6% 25.1% 28.4% 29.2% 30.0% 25.3% 26.6% 26.57%
EBITDA Margin 41.5% 41.6% 34.6% 45.2% 41.1% 41.9% 38.1% 44.2% 48.4% 42.0% 37.7% 42.7% 41.1% 44.2% 39.3% 44.5% 44.0% 44.5% 39.7% 41.6% 41.60%
FCF Margin 23.0% 23.6% 22.3% 20.4% 17.9% 15.8% 16.4% 18.0% 15.6% 17.8% 19.0% 20.0% 23.6% 25.2% 24.8% 24.6% 23.6% 23.8% 24.1% 22.5% 22.46%
OCF Margin 29.2% 29.6% 28.5% 26.9% 24.7% 23.1% 23.7% 26.6% 24.3% 26.2% 27.5% 27.5% 30.5% 32.2% 31.9% 31.7% 31.2% 31.0% 30.7% 28.6% 28.58%
ROE 3Y Avg snapshot only 59.99%
ROE 5Y Avg snapshot only 54.53%
ROA 3Y Avg snapshot only 17.17%
ROIC 3Y Avg snapshot only 22.68%
ROIC Economic snapshot only 22.60%
Cash ROA snapshot only 17.57%
Cash ROIC snapshot only 25.86%
CROIC snapshot only 20.32%
NOPAT Margin snapshot only 30.02%
Pretax Margin snapshot only 34.79%
R&D / Revenue snapshot only 7.58%
SGA / Revenue snapshot only 25.27%
SBC / Revenue snapshot only 0.96%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 44.65 44.79 54.76 41.52 37.40 32.52 31.33 36.24 35.03 34.32 37.85 31.80 33.12 35.90 29.18 29.00 26.42 24.38 20.65 18.89 12.987
P/S Ratio 11.50 11.66 14.35 10.91 9.78 8.39 8.20 9.27 9.43 9.35 10.39 8.70 8.71 9.53 7.84 7.86 7.35 6.88 5.83 5.25 3.585
P/B Ratio 22.61 23.55 24.55 18.95 17.21 14.79 15.04 17.04 17.60 17.76 17.76 15.21 15.54 17.46 15.21 15.31 14.47 13.55 16.57 14.99 10.617
P/FCF 50.08 49.35 64.26 53.56 54.70 53.05 49.95 51.47 60.34 52.45 54.74 43.44 36.92 37.79 31.56 32.01 31.10 28.85 24.17 23.38 23.376
P/OCF 39.44 39.42 50.41 40.56 39.54 36.33 34.64 34.87 38.78 35.62 37.71 31.69 28.57 29.62 24.56 24.79 23.56 22.16 19.00 18.37 18.371
EV/EBITDA 29.38 30.01 36.20 27.81 25.06 21.62 21.07 23.78 23.06 22.84 25.39 21.65 22.60 24.22 19.96 19.82 18.27 17.13 15.26 14.14 14.137
EV/Revenue 12.01 12.15 14.77 11.32 10.18 8.80 8.76 9.83 9.98 9.89 10.94 9.24 9.24 10.05 8.35 8.38 7.86 7.38 6.59 6.01 6.006
EV/EBIT 34.39 35.01 42.15 32.37 29.17 25.20 24.46 27.67 26.61 26.37 29.30 24.97 26.22 27.90 22.90 22.64 20.77 19.48 17.32 16.07 16.075
EV/FCF 52.29 51.44 66.14 55.59 56.98 55.62 53.36 54.57 63.85 55.47 57.65 46.14 39.16 39.84 33.63 34.10 33.24 30.97 27.32 26.74 26.738
Earnings Yield 2.2% 2.2% 1.8% 2.4% 2.7% 3.1% 3.2% 2.8% 2.9% 2.9% 2.6% 3.1% 3.0% 2.8% 3.4% 3.4% 3.8% 4.1% 4.8% 5.3% 5.29%
FCF Yield 2.0% 2.0% 1.6% 1.9% 1.8% 1.9% 2.0% 1.9% 1.7% 1.9% 1.8% 2.3% 2.7% 2.6% 3.2% 3.1% 3.2% 3.5% 4.1% 4.3% 4.28%
PEG Ratio snapshot only 1.575
EV/OCF snapshot only 21.013
EV/Gross Profit snapshot only 8.489
Acquirers Multiple snapshot only 15.985
Shareholder Yield snapshot only 8.59%
Graham Number snapshot only $33.32
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 3.05 3.05 3.86 3.86 3.86 3.86 2.37 2.37 2.37 2.37 3.36 3.36 3.36 3.36 1.75 1.75 1.75 1.75 3.03 3.03 3.028
Quick Ratio 2.30 2.30 2.79 2.79 2.79 2.79 1.63 1.63 1.63 1.63 2.00 2.00 2.00 2.00 1.08 1.08 1.08 1.08 1.94 1.94 1.941
Debt/Equity 1.95 1.95 1.48 1.48 1.48 1.48 1.84 1.84 1.84 1.84 1.35 1.35 1.35 1.35 1.41 1.41 1.41 1.41 2.85 2.85 2.850
Net Debt/Equity 1.00 1.00 0.72 0.72 0.72 0.72 1.02 1.02 1.02 1.02 0.94 0.94 0.94 0.94 1.00 1.00 1.00 1.00 2.16 2.16 2.156
Debt/Assets 0.54 0.54 0.49 0.49 0.49 0.49 0.54 0.54 0.54 0.54 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.61 0.61 0.614
Debt/EBITDA 2.43 2.39 2.13 2.10 2.08 2.07 2.41 2.42 2.27 2.23 1.84 1.81 1.85 1.78 1.74 1.72 1.67 1.66 2.32 2.35 2.350
Net Debt/EBITDA 1.24 1.22 1.03 1.01 1.00 1.00 1.34 1.35 1.27 1.25 1.28 1.26 1.29 1.24 1.23 1.21 1.18 1.17 1.76 1.78 1.777
Interest Coverage 10.44 10.97 11.54 11.90 12.19 12.32 12.21 11.55 12.09 12.03 12.60 13.09 12.72 13.45 13.95 14.37 15.18 15.03 15.13 14.74 14.743
Equity Multiplier 3.61 3.61 3.06 3.06 3.06 3.06 3.39 3.39 3.39 3.39 2.86 2.86 2.86 2.86 2.98 2.98 2.98 2.98 4.64 4.64 4.643
Cash Ratio snapshot only 1.034
Debt Service Coverage snapshot only 16.763
Cash to Debt snapshot only 0.244
FCF to Debt snapshot only 0.225
Defensive Interval snapshot only 451.4 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.59 0.61 0.57 0.57 0.58 0.58 0.56 0.56 0.57 0.58 0.58 0.60 0.61 0.63 0.65 0.65 0.66 0.66 0.64 0.64 0.640
Inventory Turnover 1.60 1.62 1.39 1.40 1.43 1.44 1.22 1.23 1.22 1.23 1.10 1.13 1.15 1.17 1.17 1.16 1.16 1.15 1.18 1.17 1.174
Receivables Turnover 7.06 7.26 7.25 7.35 7.45 7.46 6.88 6.89 7.00 7.13 6.78 6.93 7.08 7.27 7.07 7.09 7.16 7.17 6.52 6.54 6.544
Payables Turnover 6.40 6.50 5.52 5.57 5.68 5.72 6.19 6.23 6.19 6.26 6.64 6.78 6.92 7.07 6.78 6.72 6.67 6.62 6.07 6.05 6.046
DSO 52 50 50 50 49 49 53 53 52 51 54 53 52 50 52 51 51 51 56 56 55.8 days
DIO 229 225 263 261 255 254 299 297 299 296 331 324 317 311 311 314 316 318 309 311 310.8 days
DPO 57 56 66 66 64 64 59 59 59 58 55 54 53 52 54 54 55 55 60 60 60.4 days
Cash Conversion Cycle 223 219 247 245 240 239 293 292 293 289 329 323 316 309 309 311 312 314 305 306 306.2 days
Fixed Asset Turnover snapshot only 2.396
Operating Cycle snapshot only 366.6 days
Cash Velocity snapshot only 4.113
Capital Intensity snapshot only 1.627
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 16.9% 16.4% 16.5% 12.5% 7.9% 5.1% 3.9% 2.6% 2.8% 4.5% 5.7% 7.9% 8.4% 9.3% 8.3% 6.3% 5.3% 2.7% 2.3% 2.4% 2.40%
Net Income 18.1% 19.2% 24.4% 16.9% 9.5% 4.3% 3.8% -0.1% 5.9% 10.3% 10.9% 15.5% 5.9% 6.6% 6.1% 5.3% 11.4% 9.1% 7.5% 5.0% 4.96%
EPS 18.3% 19.7% 25.0% 17.8% 10.8% 5.9% 5.7% 1.9% 7.9% 12.1% 12.5% 16.9% 7.5% 8.4% 8.2% 7.9% 14.1% 11.6% 10.6% 11.3% 11.33%
FCF 16.9% 18.7% 3.8% -4.5% -16.0% -29.6% -23.6% -9.3% -10.1% 17.8% 22.2% 20.0% 63.7% 54.7% 41.8% 30.3% 5.5% -2.9% -0.7% -6.4% -6.36%
EBITDA 15.4% 14.1% 18.1% 11.7% 7.3% 5.7% 5.9% 4.1% 9.5% 11.1% 9.6% 11.5% 2.4% 4.8% 5.2% 5.2% 10.8% 6.7% 5.6% 2.9% 2.93%
Op. Income 23.2% 20.6% 23.5% 14.2% 6.9% 4.2% 4.5% 1.1% 4.8% 7.6% 4.8% 9.6% 8.0% 9.4% 10.5% 9.4% 9.5% 6.0% 6.0% 4.0% 3.96%
OCF Growth snapshot only -7.71%
Asset Growth snapshot only 8.64%
Equity Growth snapshot only -30.17%
Debt Growth snapshot only 40.76%
Shares Change snapshot only -5.71%
Dividend Growth snapshot only 9.48%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 9.9% 10.0% 10.1% 10.1% 9.8% 9.2% 8.9% 8.5% 9.1% 8.6% 8.6% 7.6% 6.3% 6.3% 6.0% 5.6% 5.5% 5.5% 5.4% 5.5% 5.52%
Revenue 5Y 8.8% 9.3% 9.7% 9.7% 9.8% 9.3% 8.8% 8.3% 8.0% 7.9% 8.0% 8.1% 8.1% 8.3% 8.1% 7.9% 8.2% 7.5% 7.2% 6.3% 6.28%
EPS 3Y 20.5% 20.2% 13.3% 15.0% 15.8% 13.2% 13.2% 9.8% 12.2% 12.4% 14.1% 12.0% 8.7% 8.8% 8.8% 8.7% 9.8% 10.7% 10.4% 12.0% 11.97%
EPS 5Y 25.6% 24.6% 21.0% 20.4% 20.1% 18.3% 20.8% 17.4% 15.9% 15.6% 11.6% 12.6% 12.5% 12.0% 12.0% 10.8% 11.6% 11.5% 12.2% 11.0% 11.01%
Net Income 3Y 19.6% 19.4% 12.6% 14.3% 15.0% 12.3% 12.1% 8.7% 11.0% 11.1% 12.7% 10.5% 7.1% 7.0% 6.9% 6.7% 7.7% 8.6% 8.1% 8.5% 8.47%
Net Income 5Y 24.5% 23.5% 19.9% 19.4% 18.9% 17.1% 19.6% 16.2% 14.7% 14.4% 10.4% 11.5% 11.3% 10.7% 10.6% 9.3% 10.1% 9.8% 10.3% 8.3% 8.30%
EBITDA 3Y 12.5% 12.4% 12.8% 13.0% 12.4% 10.3% 11.0% 9.0% 10.7% 10.3% 11.1% 9.1% 6.4% 7.2% 6.9% 6.9% 7.5% 7.5% 6.8% 6.5% 6.48%
EBITDA 5Y 17.9% 17.6% 15.5% 15.2% 14.5% 13.5% 11.6% 10.6% 10.8% 10.8% 10.7% 10.9% 9.7% 9.3% 9.5% 8.7% 9.0% 8.4% 8.8% 7.0% 7.03%
Gross Profit 3Y 10.4% 10.7% 11.8% 12.5% 11.9% 11.0% 10.0% 8.8% 9.7% 9.3% 9.4% 8.3% 6.9% 6.8% 6.4% 6.1% 6.4% 6.6% 6.8% 7.1% 7.11%
Gross Profit 5Y 9.6% 10.2% 10.8% 11.2% 11.4% 10.9% 9.7% 8.9% 8.7% 8.6% 9.0% 9.5% 9.3% 9.5% 9.2% 8.7% 9.0% 8.5% 8.4% 7.4% 7.42%
Op. Income 3Y 11.4% 11.1% 13.6% 14.8% 13.9% 13.2% 13.2% 10.4% 11.3% 10.6% 10.6% 8.1% 6.6% 7.0% 6.6% 6.6% 7.4% 7.7% 7.1% 7.6% 7.61%
Op. Income 5Y 16.4% 15.8% 14.9% 14.8% 14.4% 13.0% 11.2% 9.5% 9.2% 9.0% 9.9% 10.9% 10.9% 11.3% 10.9% 10.1% 10.3% 9.4% 9.7% 7.5% 7.53%
FCF 3Y 5.6% 5.5% 6.1% 3.7% -0.8% -2.5% -0.2% 3.3% -4.1% -0.5% -1.0% 1.3% 7.3% 8.7% 9.8% 12.4% 15.8% 20.9% 19.9% 13.6% 13.57%
FCF 5Y 31.2% 30.9% 28.4% 23.1% 18.4% 9.0% 3.4% 1.1% -2.3% -0.5% 2.2% 3.9% 7.5% 11.1% 11.5% 11.5% 8.8% 8.1% 6.4% 4.9% 4.90%
OCF 3Y 8.3% 7.5% 7.3% 5.8% 2.4% 1.0% 2.1% 5.9% 1.1% 3.4% 3.4% 4.2% 7.9% 9.4% 10.1% 11.5% 14.0% 16.4% 14.9% 8.1% 8.09%
OCF 5Y 26.4% 26.1% 25.4% 22.1% 19.1% 12.6% 7.3% 5.9% 3.3% 3.9% 5.6% 6.0% 8.1% 10.4% 10.5% 10.2% 8.7% 7.9% 6.4% 5.1% 5.12%
Assets 3Y 16.6% 16.6% 8.9% 8.9% 8.9% 8.9% 8.9% 8.9% 8.9% 8.9% 1.6% 1.6% 1.6% 1.6% 0.8% 0.8% 0.8% 0.8% 1.2% 1.2% 1.20%
Assets 5Y 11.5% 11.5% 12.7% 12.7% 12.7% 12.7% 11.7% 11.7% 11.7% 11.7% 5.8% 5.8% 5.8% 5.8% 4.3% 4.3% 4.3% 4.3% 2.6% 2.6% 2.59%
Equity 3Y 28.7% 28.7% 27.6% 27.6% 27.6% 27.6% 17.6% 17.6% 17.6% 17.6% 9.9% 9.9% 9.9% 9.9% 1.6% 1.6% 1.6% 1.6% -8.9% -8.9% -8.89%
Book Value 3Y 29.6% 29.5% 28.4% 28.4% 28.6% 28.7% 18.7% 18.8% 18.9% 19.0% 11.3% 11.4% 11.5% 11.7% 3.4% 3.6% 3.6% 3.6% -7.0% -6.0% -5.96%
Dividend 3Y 8.0% 8.2% 8.3% 8.7% 9.1% 9.4% 9.9% 8.5% 7.4% 6.4% 5.6% 5.7% 5.9% 6.1% 6.2% 6.3% 6.2% 6.1% 6.4% 6.4% 6.39%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.94 0.95 0.96 0.98 0.97 0.98 0.97 0.98 0.96 0.97 0.97 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.99 0.986
Earnings Stability 1.00 1.00 0.94 0.98 1.00 0.99 0.93 0.94 0.99 0.98 0.96 0.97 0.97 0.98 0.97 0.97 0.98 0.98 0.97 0.96 0.960
Margin Stability 0.98 0.98 0.98 0.97 0.97 0.97 0.98 0.98 0.99 0.99 0.98 0.97 0.98 0.98 0.98 0.99 0.99 0.98 0.98 0.98 0.979
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.93 0.92 0.90 0.93 0.96 0.98 0.98 1.00 0.98 0.96 0.96 0.94 0.98 0.97 0.98 0.98 0.95 0.96 0.97 0.98 0.980
Earnings Smoothness 0.83 0.82 0.78 0.84 0.91 0.96 0.96 1.00 0.94 0.90 0.90 0.86 0.94 0.94 0.94 0.95 0.89 0.91 0.93 0.95 0.952
ROE Trend -0.11 -0.12 -0.05 -0.08 -0.09 -0.12 0.04 0.01 0.02 0.03 0.00 0.02 -0.01 0.00 0.05 0.05 0.06 0.05 0.31 0.29 0.290
Gross Margin Trend 0.01 0.02 0.02 0.01 0.01 0.01 0.00 -0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.01 0.02 0.02 0.02 0.02 0.018
FCF Margin Trend -0.01 0.01 -0.01 -0.02 -0.05 -0.08 -0.07 -0.04 -0.05 -0.02 -0.00 0.01 0.07 0.08 0.07 0.06 0.04 0.02 0.02 0.00 0.002
Sustainable Growth Rate 45.7% 47.2% 37.6% 37.6% 37.2% 35.9% 33.6% 32.2% 34.9% 36.0% 35.1% 35.6% 34.1% 35.4% 34.8% 34.9% 36.3% 36.6% 44.0% 43.3% 43.30%
Internal Growth Rate 13.3% 13.8% 12.8% 12.8% 12.7% 12.1% 11.6% 11.1% 12.2% 12.6% 12.8% 13.0% 12.3% 12.9% 13.5% 13.6% 14.2% 14.3% 13.7% 13.4% 13.39%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.13 1.14 1.09 1.02 0.95 0.90 0.90 1.04 0.90 0.96 1.00 1.00 1.16 1.21 1.19 1.17 1.12 1.10 1.09 1.03 1.028
FCF/OCF 0.79 0.80 0.78 0.76 0.72 0.68 0.69 0.68 0.64 0.68 0.69 0.73 0.77 0.78 0.78 0.77 0.76 0.77 0.79 0.79 0.786
FCF/Net Income snapshot only 0.808
OCF/EBITDA snapshot only 0.673
CapEx/Revenue 6.2% 5.9% 6.1% 6.5% 6.9% 7.3% 7.3% 8.6% 8.7% 8.4% 8.6% 7.4% 6.9% 7.0% 7.1% 7.2% 7.6% 7.2% 6.6% 6.1% 6.12%
CapEx/Depreciation snapshot only 1.195
Accruals Ratio -0.02 -0.02 -0.01 -0.00 0.01 0.02 0.01 -0.01 0.01 0.01 -0.00 -0.00 -0.03 -0.04 -0.03 -0.03 -0.02 -0.02 -0.02 -0.01 -0.005
Sloan Accruals snapshot only 0.099
Cash Flow Adequacy snapshot only 1.848
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.5% 0.5% 0.4% 0.6% 0.7% 0.9% 0.9% 0.8% 0.8% 0.9% 0.8% 0.9% 1.0% 0.9% 1.1% 1.1% 1.2% 1.3% 1.6% 1.8% 2.53%
Dividend/Share $0.90 $0.95 $1.00 $1.07 $1.15 $1.23 $1.31 $1.36 $1.41 $1.45 $1.50 $1.56 $1.62 $1.68 $1.74 $1.81 $1.88 $1.95 $2.03 $2.10 $2.06
Payout Ratio 22.4% 22.8% 23.3% 24.6% 26.0% 27.9% 28.9% 30.5% 29.4% 29.4% 29.5% 29.9% 31.6% 31.4% 31.6% 32.2% 32.1% 32.6% 33.3% 33.6% 33.64%
FCF Payout Ratio 25.1% 25.1% 27.3% 31.7% 38.0% 45.5% 46.1% 43.3% 50.7% 45.0% 42.7% 40.9% 35.2% 33.1% 34.2% 35.6% 37.8% 38.5% 38.9% 41.6% 41.62%
Total Payout Ratio 27.5% 37.7% 59.7% 69.1% 83.8% 95.0% 1.0% 1.0% 92.2% 84.8% 76.1% 78.0% 89.5% 94.8% 1.1% 1.1% 99.7% 97.7% 1.5% 1.6% 1.62%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.24 0.25 0.25 0.27 0.28 0.29 0.30 0.25 0.21 0.17 0.14 0.14 0.15 0.15 0.15 0.15 0.14 0.14 0.15 0.11 0.113
Buyback Yield 0.1% 0.3% 0.7% 1.1% 1.5% 2.1% 2.4% 2.0% 1.8% 1.6% 1.2% 1.5% 1.7% 1.8% 2.6% 2.7% 2.6% 2.7% 5.9% 6.8% 6.81%
Net Buyback Yield 0.1% 0.3% 0.7% 1.1% 1.5% 2.1% 2.4% 2.0% 1.8% 1.6% 1.2% 1.5% 1.7% 1.8% 2.6% 2.7% 2.6% 2.7% 5.9% 6.8% 6.81%
Total Shareholder Return 0.6% 0.8% 1.1% 1.7% 2.2% 2.9% 3.3% 2.9% 2.6% 2.5% 2.0% 2.5% 2.7% 2.6% 3.6% 3.8% 3.8% 4.0% 7.5% 8.6% 8.59%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.82 0.83 0.82 0.82 0.82 0.80 0.80 0.79 0.78 0.79 0.80 0.80 0.81 0.80 0.79 0.79 0.79 0.80 0.80 0.80 0.799
Interest Burden (EBT/EBIT) 0.90 0.91 0.91 0.92 0.92 0.92 0.92 0.91 0.92 0.92 0.92 0.92 0.92 0.93 0.93 0.93 0.93 0.94 0.93 0.93 0.931
EBIT Margin 0.35 0.35 0.35 0.35 0.35 0.35 0.36 0.36 0.37 0.37 0.37 0.37 0.35 0.36 0.36 0.37 0.38 0.38 0.38 0.37 0.374
Asset Turnover 0.59 0.61 0.57 0.57 0.58 0.58 0.56 0.56 0.57 0.58 0.58 0.60 0.61 0.63 0.65 0.65 0.66 0.66 0.64 0.64 0.640
Equity Multiplier 3.88 3.88 3.31 3.31 3.31 3.31 3.22 3.22 3.22 3.22 3.11 3.11 3.11 3.11 2.92 2.92 2.92 2.92 3.67 3.67 3.667
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $4.00 $4.16 $4.28 $4.37 $4.43 $4.41 $4.53 $4.46 $4.78 $4.94 $5.09 $5.21 $5.14 $5.36 $5.51 $5.62 $5.86 $5.98 $6.09 $6.26 $6.26
Book Value/Share $7.90 $7.91 $9.55 $9.58 $9.64 $9.68 $9.44 $9.48 $9.52 $9.55 $10.86 $10.89 $10.96 $11.02 $10.57 $10.65 $10.71 $10.76 $7.59 $7.89 $7.66
Tangible Book/Share $-1.33 $-1.33 $0.81 $0.82 $0.82 $0.82 $0.60 $0.60 $0.60 $0.60 $1.96 $1.96 $1.97 $1.98 $2.04 $2.05 $2.06 $2.07 $-0.99 $-1.03 $-1.03
Revenue/Share $15.54 $15.99 $16.35 $16.64 $16.96 $17.07 $17.31 $17.42 $17.76 $18.14 $18.57 $19.04 $19.55 $20.18 $20.52 $20.73 $21.07 $21.20 $21.58 $22.51 $22.53
FCF/Share $3.57 $3.78 $3.65 $3.39 $3.03 $2.70 $2.84 $3.14 $2.78 $3.23 $3.52 $3.81 $4.61 $5.09 $5.09 $5.09 $4.98 $5.05 $5.21 $5.06 $5.06
OCF/Share $4.53 $4.73 $4.65 $4.48 $4.19 $3.94 $4.10 $4.63 $4.32 $4.76 $5.11 $5.23 $5.96 $6.49 $6.55 $6.57 $6.57 $6.58 $6.62 $6.43 $6.44
Cash/Share $7.55 $7.56 $7.32 $7.34 $7.38 $7.42 $7.66 $7.70 $7.73 $7.75 $4.43 $4.44 $4.47 $4.50 $4.40 $4.43 $4.46 $4.48 $5.27 $5.47 $4.60
EBITDA/Share $6.35 $6.47 $6.67 $6.78 $6.89 $6.95 $7.19 $7.20 $7.69 $7.85 $8.00 $8.13 $7.99 $8.37 $8.58 $8.76 $9.06 $9.14 $9.32 $9.56 $9.56
Debt/Share $15.43 $15.46 $14.18 $14.22 $14.30 $14.37 $17.33 $17.41 $17.48 $17.53 $14.68 $14.72 $14.81 $14.90 $14.95 $15.05 $15.14 $15.22 $21.64 $22.47 $22.47
Net Debt/Share $7.88 $7.89 $6.86 $6.88 $6.92 $6.95 $9.67 $9.71 $9.75 $9.78 $10.25 $10.28 $10.34 $10.40 $10.55 $10.62 $10.68 $10.74 $16.37 $17.00 $17.00
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 5.437
Altman Z-Prime snapshot only 10.683
Piotroski F-Score 9 9 9 9 7 7 6 5 6 7 7 8 7 8 7 7 7 7 8 8 8
Beneish M-Score -2.59 -2.66 -2.49 -2.43 -2.35 -2.31 -2.31 -2.45 -2.37 -2.39 -2.40 -2.41 -2.52 -2.57 -2.64 -2.61 -2.58 -2.56 -2.36 -2.33 -2.326
Ohlson O-Score snapshot only -7.359
Net-Net WC snapshot only $-12.71
EVA snapshot only $1803527629.99
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AA-
Credit Score 79.50 79.25 80.05 80.04 82.24 81.60 78.70 79.98 78.36 79.49 84.25 83.89 85.69 85.48 81.65 81.99 82.98 84.13 84.34 83.11 83.109
Credit Grade snapshot only 4
Credit Trend snapshot only 1.117
Implied Spread (bps) snapshot only 100.000
Industry Credit Rank snapshot only 64
Sector Credit Rank snapshot only 82

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms